Home » Topics » Regulatory » Patents

Patents
RSS

Sirenas describes novel cyclic peptide analogues

March 28, 2018

New Toll-like receptor 7/8 agonists patented by GlaxoSmithKline

March 27, 2018

Gilead identifies novel Toll-like receptor 8 modulators

March 27, 2018

AdPueriVitam discovers novel NMDA receptor antagonists

March 27, 2018

Jiangsu Hengrui Medicine Co., Shanghai Hengrui Pharmaceutical Co. patent factor XIa inhibitors

March 27, 2018

Bayer Pharma divluges new adenosine receptor A2B antagonists

March 27, 2018

Bristol-Myers Squibb discovers new Toll-like receptor 7, 8 and 9 antagonists

March 26, 2018

Gachon University identifies novel AChE/NO production inhibitors

March 26, 2018

Novel thrombopoietin receptor agonists synthesized at Sichuan Kelun-Biotech Biopharmaceutical

March 26, 2018

Shanghai Hansoh Biomedical, Jiangsu Hansoh Pharmaceutical Group patent CDK inhibitors

March 26, 2018

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...